Article
Variation in guideline adherence in intrauterine insemination care

https://doi.org/10.1016/j.rbmo.2009.12.016Get rights and content

Abstract

Health-care delivery according to clinical practice guidelines is thought to be critical in achieving optimal outcomes. This study aimed to assess the extent to which practice performance in intrauterine insemination (IUI) care is consistent with guideline recommendations and to evaluate the association between guideline adherence and outcome of IUI care. In a retrospective cohort study, 1100 infertile couples who underwent IUI treatment at 10 Dutch hospitals were asked to grant access to their medical record for assessment of guideline adherence using 25 systematically developed guideline-based performance indicators. A total of 558 couples who started 2334 IUI cycles participated. Guideline adherence regarding 20 process and five structure aspects of IUI care was often substandard and varied considerably between hospitals. Out of 10 possible associations investigated, guideline adherence regarding sperm quality and guideline adherence regarding the total number of IUI cycles were associated with improved ongoing pregnancy rates after IUI. Thus, guideline adherence in IUI care is far from optimal and varies substantially between hospitals. As associations between guideline adherence and ongoing pregnancy after IUI were mainly non-significant, further research is needed to evaluate associations between guideline adherence and other outcomes of IUI care besides ongoing pregnancy, such as patient safety and cost effectiveness.

Introduction

Infertility is common. As one in six couples fails to conceive within 1 year of regular unprotected sexual intercourse, approximately 72.4 million couples around the world are currently infertile (Boivin et al., 2007, Taylor, 2003). Roughly half of these couples seek medical care for their fertility problems (Boivin et al., 2007, Nachtigall, 2006). The clinical investigation and treatment of infertility has considerable physical and psychosocial implications for couples (Cousineau and Domar, 2007, Greil, 1997, Hughes, 2003, Verhaak et al., 2005). In addition, fertility treatment often carries a risk of multiple pregnancy which is associated with substantially higher rates of maternal and perinatal morbidity and mortality compared with singletons (Dickey et al., 2005, Fauser et al., 2005). The assessment and treatment of infertility is also expensive and the increased rates of adverse pregnancy outcomes add further to the resources used in health care (Goverde et al., 2000, Lukassen et al., 2004).

It is widely recognized that the quality of health care is often inadequate (Grol and Grimshaw, 2003, McGlynn et al., 2003). As infertility is a major health issue worldwide and its management is associated with health risks and high costs, there is great concern about the impact of substandard infertility care on health and health-care resources (Balen and Rutherford, 2007, Rawal et al., 2008). This prompted several professional societies in the fields of obstetrics and gynaecology, and reproductive medicine as well as governmental agencies to develop clinical practice guidelines for infertility care. These guidelines are tools to help physicians and patients to make better decisions about clinically effective, safe and cost-effective care and reduce inappropriate practice variation in infertility care. Essentially, these guidelines describe ‘the best thing to do’ and aim to improve the outcome of infertility care.

One of the most commonly used fertility treatments is homologous intrauterine insemination (IUI) (Nyboe Andersen et al., 2009). The overall success rate of IUI remains controversial. On average, reported clinical pregnancy rates are only 5–13% per IUI cycle (Bensdorp et al., 2007, Goverde et al., 2000, Guzick et al., 1999, Nyboe Andersen et al., 2009, Steures et al., 2004, Steures et al., 2007, The ESHRE Capri Workshop Group, 2009, Tummon et al., 1997, Verhulst et al., 2006). Poor guideline adherence and a high degree of inappropriate practice variation in IUI care may be responsible for these low pregnancy rates. However, up until now, there has been limited published evidence about guideline adherence in IUI care and the link between guideline adherence and outcome of IUI care. Therefore, the objective of this study was to assess the extent to which practice performance in IUI care is consistent with guideline recommendations and to evaluate the association between guideline adherence and outcome of IUI care.

Section snippets

Study design and population

This retrospective cohort study at 10 Dutch hospitals was conducted using medical record and questionnaire data. The group of participating hospitals was made up of one large academic hospital providing tertiary care and nine medium-sized public hospitals providing secondary care. Five clinics were also teaching hospitals. Patients eligible to participate in the study were defined as infertile couples who underwent IUI treatment at these 10 hospitals during an inclusion period of 28 months, from

Study population

Figure 1 presents the recruitment of eligible infertile couples for participation in the study. A total of 765 infertile couples was willing to participate. The study excluded 184 couples because they had undergone ovulation induction therapy for ovulatory disorders or IUI treatment with donated spermatozoa. Another 23 couples were excluded because there was no access to their medical records. As a result, 558 infertile couples who started a total of 2334 IUI cycles were eligible for study.

Discussion

Although guideline adherence appears adequate for some process and structure aspects of IUI care, on the whole, guideline adherence in IUI care is far from optimal. Also striking is the large variability in guideline adherence between different hospitals. Associations between ⩾90% guideline adherence and ongoing pregnancy after IUI were mainly non-significant.

Acknowledgements

The authors thank the panel of 13 experts who contributed to the development of the indicators. They also thank Sabine van den Akker and Annelies Pellegrino for assisting with data collection and Jan van Doremalen and Reinier Akkermans for assisting with the statistical analyses. The contribution of the 10 Dutch hospitals for participating and making this study possible is gratefully acknowledged: Bernhoven Hospital–Oss, Bernhoven Hospital–Veghel, Canisius Wilhelmina Hospital–Nijmegen,

References (43)

  • P. Steures et al.

    Intrauterine insemination in The Netherlands

    Reprod. Biomed. Online

    (2007)
  • I.S. Tummon et al.

    Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis

    Fertil. Steril.

    (1997)
  • A.H. Balen et al.

    Management of infertility

    Br. Med. J.

    (2007)
  • A.J. Bensdorp et al.

    Intra-uterine insemination for male subfertility

    Cochrane Database Syst. Rev.

    (2007)
  • J. Boivin et al.

    International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care

    Hum. Reprod.

    (2007)
  • S.M. Campbell et al.

    Research methods used in developing and applying quality indicators in primary care

    Br. Med. J.

    (2003)
  • S.M. Campbell et al.

    Prescribing indicators for UK general practice. Delphi consultation study

    Br. Med. J.

    (2000)
  • S.M. Campbell et al.

    Improvements in quality of clinical care in English general practice 1998–2003: longitudinal observational study

    Br. Med. J.

    (2005)
  • J.A. Cantrill et al.

    Indicators of the appropriateness of long-term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility, and reliability

    Int. J. Qual. Health Care

    (1998)
  • Danish Fertility Society (DFS), 2007. Clinical guideline No. 11: homologous intrauterine insemination. Available from:...
  • Dutch Society of Obstetrics and Gynaecology (NVOG), 2000. Clinical guideline No. 29: intrauterine insemination....
  • Cited by (14)

    • Cost-effectiveness of ovarian stimulation with gonadotrophin and clomiphene citrate in an intrauterine insemination programme for subfertile couples

      2018, Reproductive BioMedicine Online
      Citation Excerpt :

      The cost-effectiveness between IUI with clomiphene citrate or HMG was not analysed in the study by Haagen et al. (2013), as this was not the objective of their study. The fact that we added a model to calculate the ICER based on expecting couples to take part in multiple IUI cycles besides the ICER based on couples taking part in one cycle only, is in line with ‘real world practice’ where clinics and health insurance companies offering packages of IUI treatment during multiple cycles rather than IUI treatment during one cycle only (Dutch Society of Obstetrics and Gynaecology (NVOG), 2011; Dickey et al., 2002; Custers et al., 2008; ESHRE Capri Workshop Group, 2009; Haagen et al., 2010, 2013; Merviel et al., 2010). Our cumulative cost-effectiveness analysis shows that the more cycles patients have, the lower the ICER or costs per additional pregnancy achieved with HMG rather than clomiphene citrate.

    View all citing articles on Scopus

    Esther Haagen is a third-year gynaecologist-in-training at the Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. She is currently undertaking a PhD at the Radboud University Nijmegen Medical Centre within a research group interested in clinical practice guidelines, performance indicators and implementation strategies to improve infertility care. Her research is focused on intrauterine insemination care.

    View full text